|
Volumn 45, Issue 10, 2001, Pages 2771-2774
|
Acyclovir for treatment of postherpetic neuralgia: Efficacy and pharmacokinetics
a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
HUMORAL ANTIBODY;
VIRUS ANTIBODY;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE DURATION;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG CLEARANCE;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG TOLERABILITY;
FEMALE;
HERPES ZOSTER;
HUMAN;
IMMUNOCOMPETENCE;
MALE;
NERVOUS TISSUE;
PAIN;
POSTHERPETIC NEURALGIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VARICELLA ZOSTER VIRUS;
ACYCLOVIR;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIVIRAL AGENTS;
FEMALE;
HERPES ZOSTER;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NEURALGIA;
TREATMENT OUTCOME;
|
EID: 0034807103
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.45.10.2771-2774.2001 Document Type: Article |
Times cited : (32)
|
References (15)
|